IMCD Q2 Results: EBITA rises 4% to EUR 285m, FCF surges 29%
IMCD N.V. delivered solid H1 2026 results with EUR 285 million EBITA and EUR 2.6 billion revenue. Free cash flow surged 29%, supporting strategic acquisitions in South Korea, Ireland, UK, and Thailand.

*this image is generated using AI for illustrative purposes only.
IMCD N.V., a global distributor and formulator of speciality chemicals and ingredients, reported operating EBITA of EUR 285 million for the first half of 2026, representing a 4% increase from the prior period. The Rotterdam-based company also posted revenue of EUR 2,638 million, which grew by 11% on a constant currency basis, signaling robust demand across its core markets.
The financial performance was underpinned by a gross profit of EUR 658 million, up 7% on a constant currency basis, indicating improved pricing power or mix optimization within its portfolio. Free cash flow generation accelerated significantly, rising 29% to EUR 222 million compared to EUR 173 million in the first half of 2025. This liquidity improvement positions the company to fund ongoing operational initiatives and strategic investments without increasing leverage.
Key Financial Metrics
| Metric | H1 2026 | Change (YoY/CCB) |
|---|---|---|
| Revenue | EUR 2,638 million | +11% (constant currency) |
| Gross Profit | EUR 658 million | +7% (constant currency) |
| Operating EBITA | EUR 285 million | +8% (constant currency) |
| Free Cash Flow | EUR 222 million | +29% |
| Cash EPS | EUR 3.18 | vs EUR 2.94 (H1 2025) |
Cash earnings per share stood at EUR 3.18, an improvement from EUR 2.94 in the first half of 2025. This metric reflects the company’s ability to convert top-line growth into shareholder value, even as it navigates a dynamic macroeconomic environment.
Strategic Expansion
Beyond financial results, IMCD advanced its inorganic growth strategy during the period. The company completed the acquisitions of Dong Yang FT in South Korea and Willows Ingredients in Ireland and the UK. Additionally, IMCD signed an agreement for Merit Solution in Thailand, further strengthening its footprint in Asia-Pacific markets. These moves align with the company’s focus on building long-term partnerships with customers and suppliers.
Marcus Jordan, CEO of IMCD N.V., stated that the positive results were driven by organic growth in gross profit and EBITA alongside increased free cash flow generation. He emphasized the team’s ability to maintain sharp focus on commercial, operational, and digital excellence initiatives despite market dynamics.
What the Numbers Show
The divergence between the headline EBITA growth of 4% and the constant currency EBITA growth of 8% suggests that foreign exchange headwinds impacted the reported figures. However, the underlying operational performance remains strong, with gross profit growing at a faster rate than revenue, hinting at margin expansion. The significant jump in free cash flow indicates effective working capital management, allowing the company to self-fund its recent acquisition spree without diluting equity or taking on excessive debt.
How will the integration of Dong Yang FT, Willows Ingredients, and Merit Solution impact IMCD's EBITA margins in the second half of 2026?
Given the 8% constant currency EBITA growth, what specific pricing strategies or product mix shifts are driving the outperformance of gross profit relative to revenue?
Will IMCD utilize its strengthened free cash flow position to increase dividend payouts or pursue further M&A activity in emerging markets beyond Asia-Pacific?
























